Trump's Regeneron Treatment Is a Tangled Ethical Mess

Barron's - 08 Oct 2020
The president's use of an experimental drug, outside of clinical trials, raises questions about preferential treatment and imperils evidence-based ...

Regeneron resumes enrollment in lymphoma drug trials

WHBL News - 17 May 2021
Regeneron resumes enrollment in lymphoma drug trials ...

ACC 2021: Regeneron's Evkeeza aces triglyceride control, but only in certain patients

FiercePharma - 16 May 2021
ACC 2021: Regeneron's Evkeeza aces triglyceride control, but only in certain patients ...

Phase 3 Data Presented at ATS 2021 Show REGEN-COV™ (casirivimab with imdevimab) Reduced Risk of Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients

PRNewswire - 17 May 2021
Phase 3 Data Presented at ATS 2021 Show REGEN-COV™ (casirivimab with imdevimab) Reduced Risk of Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients ...

Regeneron, Weis Markets And 3 Other Unfluctuating Stocks That May Make A Move

Forbes - 17 May 2021
Regeneron, Weis Markets And 3 Other Unfluctuating Stocks That May Make A Move ...

Regeneron's Evinacumab Reduces High Triglycerides but Stumbles in Genetic Subgroup

BioSpace - 17 May 2021
Regeneron's Evinacumab Reduces High Triglycerides but Stumbles in Genetic Subgroup ...

Pivotal Data at ATS 2021 Show Dupixent® (dupilumab) Significantly Reduced Asthma Attacks and Improved Lung Function in Children

PRNewswire - 17 May 2021
Pivotal Data at ATS 2021 Show Dupixent® (dupilumab) Significantly Reduced Asthma Attacks and Improved Lung Function in Children ...

Regeneron's Evkeeza shows promise in curbing high triglycerides, but will genetic disparities limit use?

Endpoints News - 16 May 2021
Regeneron's Evkeeza shows promise in curbing high triglycerides, but will genetic disparities limit use? ...

Regeneron CEO Schleifer, chief scientist Yancopoulos bag massive $270M payday

FiercePharma - 26 Apr 2021
Regeneron CEO Schleifer, chief scientist Yancopoulos bag massive $270M payday ...

Pfizer, Regeneron CEOs see extended need for COVID-19 vaccines, treatments as pandemic enters next phase

FiercePharma - 11 May 2021
Pfizer, Regeneron CEOs see extended need for COVID-19 vaccines, treatments as pandemic enters next phase ...

Regeneron Earnings Lift Stock. Here's Why.

Barron's - 06 May 2021
Regeneron Earnings Lift Stock. Here's Why. ...

How Regeneron developed its COVID-fighting antibody cocktail

Fast Company - 04 May 2021
How Regeneron developed its COVID-fighting antibody cocktail ...

Regeneron looks to inject another $330M into long-running manufacturing expansion plan: report

FiercePharma - 23 Apr 2021
Regeneron looks to inject another $330M into long-running manufacturing expansion plan: report ...

Polen Focus Growth Fund Disposed its Regeneron Pharmaceuticals (REGN) Position, Here’s Why

Yahoo Finance - 14 May 2021
Polen Focus Growth Fund Disposed its Regeneron Pharmaceuticals (REGN) Position, Here’s Why ...

Buy Alert: Regeneron Stock Is Headed Higher

Motley Fool - 28 Apr 2021
Buy Alert: Regeneron Stock Is Headed Higher ...

India approves Roche/Regeneron antibody cocktail to treat COVID-19

Reuters India - 05 May 2021
India approves Roche/Regeneron antibody cocktail to treat COVID-19 ...

Recon: Sanofi, GKS report positive interim results for COVID shot; Regeneron resumes lymphoma trials after hold lifted

Regulatory Focus - 17 May 2021
Recon: Sanofi, GKS report positive interim results for COVID shot; Regeneron resumes lymphoma trials after hold lifted ...

Can Regeneron make 'monoclonal antibodies' a catchphrase? New COVID-19 ad campaign gives it a go

FiercePharma - 28 Apr 2021
Can Regeneron make 'monoclonal antibodies' a catchphrase? New COVID-19 ad campaign gives it a go ...

Up 6% Last Week Can Regeneron Pharmaceuticals Stock Rise Further?

Forbes - 20 Apr 2021
Up 6% Last Week Can Regeneron Pharmaceuticals Stock Rise Further? ...

Regeneron and Sanofi updates data from late-stage trial for Libtayo in cervical cancer

Seeking Alpha - 12 May 2021
Regeneron and Sanofi updates data from late-stage trial for Libtayo in cervical cancer ...

Regeneron